Shuttle Pharmactcls Hldgs Inc.
13F holders, Q1 2025 (March 31)8holders +2
3new positions
1sold out
1famous investor
$0.39avg. 13F price*
At the end of Q1 2025, 8 institutions reported holding Shuttle Pharmactcls Hldgs Inc. in their 13F filings, up 2 from Q4 2024. 3 opened new positions and 1 sold out. The largest holders were Citadel Advisors ($37K), Armistice Capital, LLC ($27K) and Geode Capital Management, LLC ($13K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Shuttle Pharmactcls Hldgs Inc.
- CUSIP
- 825693302
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $46K |
| Exits | 1 | $28K |
All 13F filers, Q4 2024 → Q1 2025: 140,128 shares bought and 271,911 shares sold, net −131,783 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Citadel Advisors | 0.00% | New | 94,916 | $37K |
| Armistice Capital, LLC | 0.00% | Reduce -77.0% | 70,399 | $27K |
| Geode Capital Management, LLC | 0.00% | Add +211.8% | 33,884 | $13K |
| Two Sigma Securities, LLC | 0.00% | New | 22,189 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -50.5% | 3,397 | $1K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 63 | $25 |
| Bank of America Corp. | 0.00% | Add +13.0% | 26 | $10 |
| Barclays PLC | 0.00% | New | 3 | $1 |
"% of holder's portfolio" is SHUTTLE PHARMACTCLS HLDGS IN's weight in each manager's 13F, not the share of Shuttle Pharmactcls Hldgs Inc. the manager owns.